Circulating cell-free human telomerase reverse transcriptase mRNA in plasma and its potential diagnostic and prognostic value for gastric cancer

International Journal of Clinical Oncology

Volumn 18, Issue 3, 2013, Pages 478-486

  Kang, Yi ^a   Zhang, Jiancheng ^a   Sun, Peichun ^a   Shang, Jia ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Circulating cell free hTERT mRNA; Diagnosis; Gastric cancer; Plasma; Prognosis

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; ARTICLE; ATROPHIC GASTRITIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; SURVIVAL TIME;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RNA, MESSENGER; STOMACH NEOPLASMS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84879421350     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-012-0405-9     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. Menges M (2011) Gastric cancer: Where is the place for the surgeon, the oncologist and the endoscopist today? World J Gastrointest Oncol 3:10-13
3. Dilege E, Mihmanli M, Demir U et al (2010) Prognostic value of preoperative CEA and CA19-9 levels in resectable gastric cancer. Hepatogastroenterology 57:674-677
4. Schneider J, Schulze G (2003) Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer. Anticancer Res 23:5089-5093
5. Kopreski MS, Benko FA, Kwak LW et al (1999) Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 5:1961-1965
6. Schwarzenbach H, Hoon DS, Pantel K (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11:426-437
7. Dasi F, Martinez-Rodes P, March JA et al (2006) Real-time quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer. Ann N Y Acad Sci 1075:204-210
8. Kudo Y, Ochi T, Shimada H et al (2008) Utility of plasma circulating mRNA as a marker to detect hepatic injury. J Vet Med Sci 70:993-995
9. Takahashi S, Miura N, Harada T et al (2010) Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study. J Transl Med 8:103
10. Garcia V, Garcia JM, Pena C et al (2008) Free circulating mRNA in plasma from breast cancer patients and clinical outcome. Cancer Lett 263:312-320
11. Garcia V, Garcia JM, Silva J et al (2009) Extracellular tumor-related mRNA in plasma of lymphoma patients and survival implications. PLoS ONE 4:e8173
12. Nakamura TM, Morin GB, Chapman KB et al (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959
13. Yuan J, Yang BM, Zhong ZH et al (2009) Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase. Oncogene 28:2678-2689
14. Xu Y, Yu M, Wu F et al (2009) Effects of ectopic expression of human telomerase reverse transcriptase on immortalization of feather keratinocyte stem cells. J Exp Zool B Mol Dev Evol 312:872-884
15. Yip YL, Tsang CM, Deng W et al (2010) Expression of Epstein-Barr virus-encoded LMP1 and hTERT extends the life span and immortalizes primary cultures of nasopharyngeal epithelial cells. J Med Virol 82:1711-1723
16. Mai W, Kawakami K, Shakoori A et al (2009) Deregulated GSK3{beta} sustains gastrointestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase. Clin Cancer Res 15:6810-6819
17. Suzuki K, Kashimura H, Ohkawa J et al (2000) Expression of human telomerase catalytic subunit gene in cancerous and precancerous gastric conditions. J Gastroenterol Hepatol 15:744-751
18. Yoo J, Park SY, Kang SJ et al (2003) Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas. Mod Pathol 16:700-707
19. Wang W, Luo HS, Yu BP (2004) Expression of NF-kappaB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions. World J Gastroenterol 10:177-181
20. Gigek CO, Leal MF, Silva PN et al (2009) hTERT methylation and expression in gastric cancer. Biomarkers 14:630-636
21. Chen XQ, Bonnefoi H, Pelte MF et al (2000) Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 6:3823-3826
22. Miura N, Nakamura H, Sato R et al (2006) Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer. Cancer Sci 97:1366-1373
23. Tani N, Ichikawa D, Ikoma D et al (2007) Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer. Anticancer Res 27:1207-1212
24. Miura N, Shiota G, Nakagawa T et al (2003) Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma. Oncology 64:430-434
25. Khan FA, Shukla AN (2006) Pathogenesis and treatment of gastric carcinoma: "an up-date with brief review". J Cancer Res Ther 2:196-199
26. Yang SM, Fang DC, Yang JL et al (2008) Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. Eur J Cancer Prev 17:209-217
27. Ebert MP, Rocken C (2006) Molecular screening of gastric cancer by proteome analysis. Eur J Gastroenterol Hepatol 18:847-853
28. Oh BK, Kim H, Park YN et al (2008) High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis. Lab Invest 88:144-152
29. Taubert H, Wurl P, Greither T et al (2007) Stem cell-associated genes are extremely poor prognostic factors for soft-tissue sarcoma patients. Oncogene 26:7170-7174
30. Chen HH, Yu CH, Wang JT et al (2007) Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan. Oral Oncol 43:122-129
31. Boldrini L, Pistolesi S, Gisfredi S et al (2006) Telomerase activity and hTERT mRNA expression in glial tumors. Int J Oncol 28:1555-1560
32. Metzger R, Vallbohmer D, Muller-Tidow C et al (2009) Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer. Anticancer Res 29:1157-1162
33. Grochola LF, Greither T, Taubert HW et al (2008) Prognostic relevance of hTERT mRNA expression in ductal adenocarcinoma of the pancreas. Neoplasia 10:973-976
34. Kawai J, Kodera Y, Fujiwara M et al (2005) Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach. Hepatogastroenterology 52:959-964